Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

89 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.
Gogas H, Dafni U, Koon H, Spyropoulou-Vlachou M, Metaxas Y, Buchbinder E, Pectasides E, Tsoutsos D, Polyzos A, Stratigos A, Markopoulos C, Panagiotou P, Fountzilas G, Castana O, Skarlos P, Atkins MB, Kirkwood JM. Gogas H, et al. Among authors: buchbinder e. J Transl Med. 2010 Nov 3;8:108. doi: 10.1186/1479-5876-8-108. J Transl Med. 2010. PMID: 21044351 Free PMC article.
Long-term Overall Survival and Predictors in Anti-PD-1-naive Melanoma Patients With Brain Metastases Treated With Immune Checkpoint Inhibitors in the Real-world Setting: A Multicohort Study.
Naik GS, Buchbinder EI, Cohen JV, Manos MP, Johnson AEW, Bowling P, Aizer AA, Schoenfeld JD, Lawrence DP, Haq R, Hodi FS, Sullivan RJ, Ott PA. Naik GS, et al. Among authors: buchbinder ei. J Immunother. 2021 Oct 1;44(8):307-318. doi: 10.1097/CJI.0000000000000385. J Immunother. 2021. PMID: 34406158
Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study.
Bui AN, Bougrine A, Buchbinder EI, Giobbie-Hurder A, LeBoeuf NR. Bui AN, et al. Among authors: buchbinder ei. J Am Acad Dermatol. 2021 Jul 9:S0190-9622(21)02087-9. doi: 10.1016/j.jaad.2021.06.885. Online ahead of print. J Am Acad Dermatol. 2021. PMID: 34252467 No abstract available.
Immune Checkpoint Therapies for Melanoma.
Buchbinder EI. Buchbinder EI. Hematol Oncol Clin North Am. 2021 Feb;35(1):99-109. doi: 10.1016/j.hoc.2020.08.013. Epub 2020 Oct 26. Hematol Oncol Clin North Am. 2021. PMID: 33759776 Review.
Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors.
Tyan K, Baginska J, Brainard M, Giobbie-Hurder A, Severgnini M, Manos M, Haq R, Buchbinder EI, Ott PA, Hodi FS, Rahma OE. Tyan K, et al. Among authors: buchbinder ei. Cancer Immunol Immunother. 2021 Aug;70(8):2209-2221. doi: 10.1007/s00262-021-02855-1. Epub 2021 Jan 22. Cancer Immunol Immunother. 2021. PMID: 33481042
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma.
Hu Z, Leet DE, Allesøe RL, Oliveira G, Li S, Luoma AM, Liu J, Forman J, Huang T, Iorgulescu JB, Holden R, Sarkizova S, Gohil SH, Redd RA, Sun J, Elagina L, Giobbie-Hurder A, Zhang W, Peter L, Ciantra Z, Rodig S, Olive O, Shetty K, Pyrdol J, Uduman M, Lee PC, Bachireddy P, Buchbinder EI, Yoon CH, Neuberg D, Pentelute BL, Hacohen N, Livak KJ, Shukla SA, Olsen LR, Barouch DH, Wucherpfennig KW, Fritsch EF, Keskin DB, Wu CJ, Ott PA. Hu Z, et al. Among authors: buchbinder ei. Nat Med. 2021 Mar;27(3):515-525. doi: 10.1038/s41591-020-01206-4. Epub 2021 Jan 21. Nat Med. 2021. PMID: 33479501 Free PMC article.
89 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page